Genetics and pathogenesis of multiple sclerosis

Overview of attention for article published in Seminars in Immunology, September 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

policy: 1 policy source

patent: 9 patents

Readers on

mendeley: 135 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Cladribine for treating relapsing–remitting multiple sclerosis : Committee papers for TA493

Cited by National Institute for Health and Care Excellence (NICE) on 26 Oct 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.